Related Experiment Video
Updated: Jul 25, 2025

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and
Amitai Segev1, Yishay Wasserstrum1, Michael Arad1
1Leviev Heart Center, Sheba Medical Center, Affiliated With Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Insights
In hypertrophic cardiomyopathy (HCM), ventricular tachycardia (VT) is more common than ventricular fibrillation (VF). Antitachycardia pacing (ATP) is effective for VT in HCM patients with specific left ventricular (LV) characteristics.
Area of Science:
- Cardiology
- Electrophysiology
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is associated with an elevated risk of sudden cardiac death, often attributed to ventricular fibrillation (VF).
- Understanding the specific arrhythmias in HCM is crucial for risk stratification and management.
Purpose of the Study:
- To determine the incidence and predictors of sustained ventricular arrhythmias (VTAs) in patients with HCM.
- To compare the characteristics of VF versus ventricular tachycardia (VT) in this population.
Main Methods:
- Retrospective analysis of HCM patients with implantable cardioverter-defibrillators (ICDs) from a prospectively collected registry.
- Collection and comparison of clinical, electrocardiographic, echocardiographic, ICD interrogation, and genetic data.
Main Results:
- Sustained VTAs occurred in 18% of HCM patients with ICDs over a mean follow-up of 10 years.
- Ventricular tachycardia (VT), particularly monomorphic VT, was the most common arrhythmia (70%), associated with decreased left ventricular ejection fraction and increased LV dimensions.
- Antitachycardia pacing (ATP) successfully terminated 79% of VT events; mortality rates were similar between patients with and without VTAs.
Conclusions:
- Ventricular tachycardia (VT), not VF, is the predominant arrhythmia in HCM patients requiring ICDs.
- VT in HCM is often responsive to ATP and linked to specific left ventricular (LV) structural abnormalities.
- ATP-capable ICDs may be beneficial for HCM patients exhibiting these LV features.
Background:
Hypertrophic cardiomyopathy (HCM) carries an increased risk of sudden cardiac death. Ventricular fibrillation (VF) is thought to be the common culprit arrhythmia.
Objective:
The purpose of this study was to describe the incidence and predictors of sustained ventricular arrhythmias (VTAs) in HCM patients.
Methods:
We retrospectively analyzed all patients with HCM and an implantable cardioverter-defibrillator (ICD) from a prospectively derived registry in 2 tertiary medical centers. Clinical, electrocardiographic, echocardiographic, ICD interrogation, and genetic data were collected and compared, first between patients with and without VTAs and then between patients with only VF and those with ventricular tachycardia (VT) with or without VF.
Results:
Of the 1328 HCM patients, 207 (145 [70%] male; mean age 33 ± 16 years) were implanted with ICDs. Over a mean follow-up of 10 ± 6 years, 37 patients with ICDs (18%) developed sustained VTAs. These were associated with a family history of sudden cardiac death and a personal history of VTAs (P = .036 and P = .001, respectively). Sustained monomorphic VT was the most common arrhythmia (n = 26, 70%) and was linked to decreased left ventricular (LV) ejection fraction and increased LV end-systolic and end-diastolic diameters. Antitachycardia pacing (ATP) successfully terminated 258 (79%) of the 326 VT events. Mortality rates were comparable between patients with and without VTAs (4 [11%] vs 29 [17%]; P = .42) and between those with and without ICDs (24 [16%] vs 85 [20%]; P = .367).
Conclusion:
VT rather than VF is the most common arrhythmia in patients with HCM; it is amenable to ATP and is associated with lower LV ejection fraction and higher LV diameters. Therefore, ATP-capable devices may be considered in HCM patients with these LV features.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mechanism of Cardiac Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy